journal clubs | مرکز تحقیقات غدد و متابولیسم

ردیف	تاریخ ارائه	توضیحات
1	1405/5/1	Semaglutide in Modern Endocrinology From Glycemic Control to Multiorgan Protection
2	1405/3/21	سیتولوژی ندولهای تیروئید (AUS)
3	1405/07/23	Metabolic therapies, disease modification and the next generation of diabetes care
4	1405/07/16	Tirzepatide
5	1405/07/09	Responders Vs. Non-Responders or How to Predict the Response to GLP-1 or GLP-1/GIP Receptor Agonist Therapy
6	1405/07/02	Approach to the patient with thyroid storm
7	1405/06/26	Diabetic Foot Ulcers
8	1405/06/19	Central precocious puberty
9	1405/06/12	Osteoporosis A Review
10	1405/06/05	Evidence-based guideline: premature ovarian insufficiency
11	1405/05/29	Combination treatment for the management of chronic kidney
12	1405/05/15	هایپرتیروئید در بارداری
13	1405/05/08	تیروئید در بارداری
14	1405/04/18	Precision_Pituitary_Radiosurgery
15	1405/04/11	تشخیص بیماری کبد چرب و آشنایی با داروی Resmetirom
16	1405/02/31	کاربرد بالینی و مدیریت عوارض دارویی Tirzepatide
17	1405/02/24	hypercalcemia of malig
18	1405/02/17	Neuropathy, and Foot Care: Standards of Care in Diabetes—2026
19	1404/7/3	2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
20	1404/2/18	The Porphyrias Disorders of Heme Synthesis
21	1404/2/11	Guideline for the Prevention and Treatment
22	1404/11/9	Case Presention
23	1404/11/30	Transition from childhood to adulthood in classic CAH
24	1404/11/23	درمان دارویی چاقی
25	1404/11/2	prolactinoma
26	1404/11/16	Revised European Society of Endocrinology Clinical Practice Guideline
27	1404/10/4	management of metabolic dysfunction-associated steatotic liver disease (MASLD)
28	1404/10/25	Finerinone from clinical needs to clinical application
29	1404/10/18	Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
30	1404/10/11	Standards of Care in Diabetes-2026
31	1404/1/28	HYPERTHYROHDISM
32	1404/1/21	Rdioactive Lodin Therapy
33	1404/09/27	Management of parathyroid disorders
34	1404/09/20	Evaluation and management of menopause and the perimenopause
35	1404/09/13	Sarcopenia in Patients with Type 2 Diabetes Mellitus
36	1404/08/29	European Society of Endocrinology and Endocrine Society Joint Clinical Guideline
37	1404/07/24	ATA-2025
38	1404/07/17	ATA Management Guidelines 2025 for Adult Patients with Differentiated Thyroid
39	1404/07/10	American Thyroid Association Management Guidelines 2025 for Adult Patients with Differentiated Thyroid Cancer
40	1403/12/9	Onset and progression of osteoporosis
41	1403/12/23	Diabetes insipidus
42	1403/12/2	screening or not screening T1D ISPAD 2024 Recommendations
43	1403/12/16	Ramadan and Diabetes
44	1403/11/25	Insulin Resistance and Diabetes Mellitus
45	1403/11/18	Adrenal cortical carcinoma
46	1403/11/11	Management of diabetic foot ulcers
47	1403/10/27	DIABETES AND CANCER
48	1403/10/20	Management of challenging and complicated patients with DM
49	1403/10/13	Dyslipidemia management in pregnant patients: a 2024 update
50	1403/10/06	Adrenal insufficiency:identification and management
51	1403/09/29	Pheochromocytoma and paraganglioma in children
52	1403/09/01	How to manage Cushing’s disease after failed primary pituitary surgery
53	1403/08/24	Surgery of the Adrenal Glands
54	1403/08/24	Surgical Approaches to the Adrenal Gland
55	1403/08/17	Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows
56	1403/08/10	Acromegaly
57	1403/08/03	BEMPEDOIC ACID, DEVELOPMENT AND CLINICAL APPLICATION
58	1403/07/26	postmenopausal osteoporosis
59	1403/07/19	Late night salivary cortisol
60	1403/07/19	Salivary Cortisol test
61	1403/07/12	CKD-MBD
62	1403/07/05	Clinical Indication of FDG PET-CT in DTC
63	1403/04/14	The Genetic Testing in Endocrine Disorders
64	1403/03/31	Cyclic Cushing’s Disease
65	1403/03/20	Primary Aldosteronism Novel Approaches and Future Outlooks
66	1403/03/17	Diabetic Nephropathy
67	1403/03/10	GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
68	1403/03/03	2023 European Thyroid Association Clinical Practice Guidelines for Thyroid nodule management
69	1403/02/27	Bariatric Surgery
70	1403/02/13	Abnormal uterine bleeding in adolescents: Management
71	1403/02/06	Multimodality imaging of primary hyperparthyroidism
72	1403/01/30	Perioperative Evaluation and Management of Patients on Glucocorticoids
73	1403/01/16	Review of ICE 2024
74	1402/12/24	Management of Advanced Thyroid Cancer: Overview, Advances, and Opportunities
75	1402/12/17	Medical Nutrition Therapy IN Diabetes
76	1402/12/10	Diabetic Bladder or Diabetic Cystopathy &related complicationc
77	1402/12/03	The Revolution in Cholesterol Management: Putting REPATHA into practice
78	1402/11/26	EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
79	1402/11/12	Glucocorticoidinduced osteoporosis (GIOP)
80	1402/10/28	Thyroid Scintigraphy
81	1402/10/21	MTC
82	1402/10/14	Summary of Revisions: Standards of Medical Care in Diabetes—2024
83	1402/10/07	Summary of Revisions: Standards of Medical Care in Diabetes—2024
84	1402/09/30	OBESITY MANAGEMENT IN ADULTS
85	1402/09/23	Prolactinomas
86	1402/09/16	Updates on Thyroid eye disease
87	1402/09/09	Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines
88	1402/08/25	Nuclear Medicine In Diabetic Foot
89	1402/08/18	Syndrome of Inappropriate Antidiuresis
90	1402/08/11	Hypothyroidism
91	1402/08/04	Management of Osteoporosis in Postmenopausal Woman
92	1402/07/27	EVALUATION & MANAGEMENT OF INFANT WITH DSD
93	1402/07/21	PCOS GUIDLINE 2023
94	1402/07/13	Adrenal Incidentaloma
95	1402/07/06	Acromegaly original
96	1401/08/10	Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
97	1400/04/04	A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
98	1400/03/28	Type 1 Diabetes: Management in Women From Preconception to Postpartum
99	1400/03/21	American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool
100	1400/03/07	Vitamin D Update
101	1400/02/31	Active Surveillance of Adult Low-Risk Papillary Thyroid Carcinoma
102	1400/02/17	Management of Hypertriglyceridemia
103	1400/02/10	Adrenal Incidentaloma
104	1400/02/03	Diagnosis and Treatment of NCCAH due to 21-Hydroxylase Deficiency
105	1400/01/27	New Oral Options for Diabetic Dyslipidemia Managment
106	1400/01/20	Testosterone Deficiency in Men
107	1399/12/22	The Evolution of the Primary Aldosteronism Syndrome: Updating the Approach
108	1399/12/15	Role of Nuclear Medicine in Endocrinology
109	1399/12/08	Pituitary Disorders in Pregnancy
110	1399/12/01	IDF DaR Guideline for people with diabetes who want to fast in Ramadan
111	1399/11/24	Thyroid Eye Disease: Managing a Condition with Grave Consequences
112	1399/11/17	Dyslipidemia in Children
113	1399/11/10	Clinical Indication of FDG PET-CT in DTC
114	1399/11/03	Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes
115	1399/10/26	Practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (NET)
116	1399/10/19	Lipid Management in Patients with Endocrine Disorders
117	1399/10/12	Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
118	1399/10/05	ADA 2021 Review
119	1399/09/28	Management of Graves‘ Thyroidal and Extrathyroidal Disease – An Update
120	1399/09/21	Approach to Managing a Postmenopausal Patient
121	1399/09/14	Endocrine Surgery during the Covid-19 pandemic
122	1399/09/07	Turner Syndrome Genome
123	1399/08/30	Glucocorticoid-Induced Osteoporosis
124	1399/08/09	Pituitary Incidentalomas
125	1399/08/02	How to use TBS in combination with BMD in clinical practice
126	1399/07/25	Glucocorticoid Induce Hyperglycemia
127	1399/07/18	Hypoparathyroidism
128	1399/07/11	Normocalcaemic Primary Hyerparathyroidism Normocalcaemic PHP
129	1399/07/04	GLP-1 AGONISTS vs SGLT2-inh ECE 2020
130	1399/03/27	PDE5 Inhibitors in Type 2 Diabetes Mellitus
131	1399/03/20	Dietary Fats and Health Outcome
132	1399/03/13	Medical Treatment with Somatostatin Analogues & Predictive Markers for Post-Surgical Medical Management of Acromegaly
133	1399/03/06	Pituitary-Tumor Endocrinopathies
134	1399/02/30	Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
135	1399/02/23	Osteoporosis in Men
136	1399/02/16	PCOS in Adolescents
137	1399/02/09	Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline
138	1399/02/02	Diabetes & Ramadan Fasting - 2020
139	1399/01/26	COVID-19 and Endocrine System
140	1399/01/20	European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
141	1398/11/29	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
142	1398/11/15	Prolactinoma in Pregnancy and Menopause
143	1398/11/08	Nuclear Medicine & Parathyroid Diseases
144	1398/11/01	Management of Hypopituitarism
145	1398/10/24	Thermal Ablation for Papillary Thyroid Microcarcinomas
146	1398/10/17	ADA 2020 - Standards of Medical Care in diabetes
147	1398/10/10	2019European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
148	1398/10/03	Hypogonadism in Men
149	1398/09/26	Prolactinoma in Pregnancy
150	1398/09/19	Familial hypercholesterolemia in children “Diagnosis and Treatment “
151	1398/09/12	Contemporary Debates in Adult Papillary Thyroid Cancer Management
152	1398/09/05	Management Of Graves Orbitopathy
153	1398/08/28	Management of Difficult Osteoporosis
154	1398/08/21	Medical Management of Cushing’s Syndrome
155	1398/08/14	Prolactinoma
156	1398/07/30	Adrenal Crisis
157	1398/07/23	Drug Effects on the Thyroid
158	1398/07/16	Lipid
159	1398/07/09	Pheochromocytoma and Paraganglioma
160	1398/07/02	AROMATASE INHIBITORS AND BONE - ECE 2019
161	1398/03/28	Endocrine Treatment of Gender - Dysphoric/Transsexual Person
162	1398/03/21	Principles of DXA Scan Interpretation
163	1398/03/07	The Indeterminate Thyroid Nodule
164	1398/02/31	Prevention of Type 1 Diabetes
165	1398/02/24	Management of Medullary Thyroid Cancer
166	1398/02/17	Adrenal Imaging
167	1398/02/10	Osteoprosis Recumendations
168	1398/02/03	The Evaluation of Incidentally Discovered Adrenal Masses
169	1398/01/27	Update on Central Precocious Puberty: From Etiologies to Outcomes
170	1398/01/20	Treatment of Diabetes in Older Adults
171	1397/12/21	Diabetes Technology: Standards of Medical Care in Diabetes 2019
172	1397/12/14	The Management of Primary Aldosteronism Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
173	1397/12/07	Sglt2 Inhibitor
174	1397/11/30	Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
175	1397/11/23	BMD
176	1397/11/16	Thyroid and Pregnancy
177	1397/11/09	Long-term Safety & Efficacy of GH Treatment
178	1397/11/02	Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
179	1397/10/25	The Diagnosis and Management of Nonalcoholic Fatty Liver Disease
180	1397/10/18	Gaps in Guidelines for the Management of Diabetes in Low and Middle-Income Versus High-Income Countries: A Systematic Review
181	1397/10/11	RAI in low risk DTC
182	1397/10/04	Management of Hyperglycemia in Type 2 Diabetes, 2018
183	1397/09/27	Diabetic Neuropathy
184	1397/09/20	OSTEOGENESIS IMPERFECTA
185	1397/09/13	Conventional & New Treatments of Hypoparathyroidism
186	1397/09/06	CONGENITAL ADRENAL HYPERPLASIA
187	1397/08/29	ORAL SEMAGLUTIDE vs PLACEBO
188	1397/08/15	ACROMEGALY
189	1397/08/01	2018European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction
190	1397/07/24	Adrenocortical Carcinoma
191	1397/07/17	Gestational Diabetes Underpinning Principles, Surveillance, and Management
192	1397/07/10	2018European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
193	1397/07/03	Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
194	1397/03/29	Charcot Foot
195	1397/03/22	X-linked Hypophosphatemic Rickets and its Treatment with Anti-FGF23
196	1397/03/08	Differentiated Thyroid Cancer Subtypes and Prognosis
197	1397/03/01	Incidence of Bone Metastases in Differentiated Thyroid Cancer
198	1397/02/25	Ramadan Fasting & Health
199	1397/02/18	Testosterone Therapy in Men With Hypogonadism
200	1397/02/11	Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
201	1397/01/28	Acromegaly: An Endocrine Society Clinical Practice Guideline
202	1397/01/21	European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
203	1397/01/14	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
204	1396/12/22	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Managment Algorithm-2018 Executive Summary
205	1396/12/15	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
206	1396/12/08	Some Points & Recommendations for Diagnosis Growth Hormone Deficiency in Children and Adolescents
207	1396/11/24	Definition of Pheochromocytomaand Paraganglioma (PPGL)
208	1396/11/17	Magnetic Resonance Imaging of Pituitary Tumors
209	1396/11/10	Diagnosis and Treatment PCOS
210	1396/11/03	Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline
211	1396/10/26	KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, revention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
212	1396/10/19	Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents
213	1396/10/12	Clinically Nonfunctioning Pituitary Adenomas
214	1396/10/05	Standards of Medical Care in Diabetes - 2018
215	1396/09/28	AACE FOR MANAGEMENT OF DYSLIPIDEMIA
216	1396/09/14	Pituitary Apoplexy
217	1396/09/07	Non-Classic Congenital Adrenal Hyperplasia
218	1396/08/30	Nuclear Medicine in Neuroendocrine Tumors
219	1396/08/23	Type 2 Diabetes and Osteoporosis
220	1396/08/16	The Management of Primary Aldosteronism
221	1396/08/09	Prolactinoma
222	1396/08/02	PERIPHERAL PRECOCITY
223	1396/07/25	The follicular-variant papillary thyroid cancer (FVPTC)
224	1396/07/18	Gestational Diabetes Mellitus
225	1396/07/11	Approach to the Patient with Progressive Radioiodine-Refractory Thyroid Cancer - When to Use Systemic Therapy
226	1396/07/04	Management of Graves Orbitopathy ECE2017
227	1396/03/30	Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline
228	1396/03/23	Pathogenesis and management of hypoglycemia
229	1396/03/16	Diabetes and Ramadan
230	1396/03/09	Combination Therapy in DM2
231	1396/03/02	Gastrointestinal Manifestations of Diabetes
232	1396/02/26	Ovarian Hyperthecosis
233	1396/02/19	Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
234	1396/02/12	An update on sodium-glucose co transporter-2 inhibitors for the treatment of diabetes mellitus
235	1396/01/15	Physiological and molecular responses to bariatric
236	1395/12/17	Physical activity and exercise in children with diabetes mellitus type 1
237	1395/12/10	Pseudohypoparathyroidism, Albright’s Hereditary Osteodystrophy-Disorders Caused by Inactivating GNAS Mutations
238	1395/11/26	Management of Osteoporosis
239	1395/11/19	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
240	1395/11/12	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
241	1395/11/07	Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly
242		Alcohol Ablation It’s indication, Efficacy, and Safety in Thyroid Disease
243		Central precocious puberty
244		Postoperative Management Following Pituitary Surgery
245		Diabetes and Ramadan: Practical Guidelines
246		The Increasing Incidence of Thyroid Cancer
247		EASD (2016)
248		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules
249		Achieving and Maintaining Weight Loss in Obesity: Clinical Evidence for Novel Approaches
250		European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for phaeochromocytomaor a paraganglioma
251		Approach to diabetes mellitus in children and Adolescents
252		Postmenopausal Osteoporosis
253		Diagnostic tests of cushing syndrome
254		RED CELL TRANSFUSION
255		DPP-4 inhibitors
256		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
257		Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
258		Limitation of current approaches for the treatment of acromegaly
259		COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM
260		Primary ovarian insufficiency (POI)
261		Comprehensive Type 2 Diabetes Managment Algorithm (part 2)
262		Primary Male Hypogonadism and Testosterone Therapy
263		Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
264		Timing of multiple endocrine neoplasia thyroidectomy and extent of central nacklymphadenectomy
265		Hyperglycemia Management In Patients With Post Transplantation Diabetes
266		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
267		Premature Ovarian Failure Clinical Presentation and Treatment
268		Clinical Practice Guidlines for the Diagnosis and Treatment of Postmenopausal Osteoprosis (2016)
269		Premature adrenarche
270		Diabetic Sensory and Motor Neuropathy
271		Update on subclinical thyroid dysfunction
272		Thyroid lymphoma
273		Glinids & Metformin
274		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis
275		Pharmacotherapy for obesity and type 2 diabetes
276		Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR<45 <span data-scayt_word="mL" data-scaytid="146">mL/min) - Dr.Karimifard
277		Postsurgical hypoparathyroidism definitions and management
278		Standards of Medical Care in Diabetes — 2016
279		Thiazolidinediones Alpha and Glucosidase Inhibitors
280		Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly: A Metaanalysis
281		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis part 2